Big Pharma Split Corp. Announces Board Changes

Big Pharma Split Corp. is a Canada-based investment fund. The Company’s investment objectives for the Preferred shares are to provide their holders with fixed cumulative preferential quarterly cash distributions in the amount of $0.125 per Preferred share and to return the original issue price of $10.00 to holders on the maturity date. Its investment objectives for the Class A shares are to provide their holders with regular monthly non-cumulative cash distributions targeted to be $0.1031 per Class A share representing a yield on the issue price of the Class A shares of 8.25% per annum on the issue price of $15.00 per Class A share and to provide holders with the opportunity for growth in the net asset value per Class A share. It will invest in an initially equally weighted portfolio (the Portfolio) comprised of Equity Securities of ten issuers, selected by the portfolio manager from the investable universe. Its portfolio manager is Harvest Portfolios Group Inc.